Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.
UnitedHealth Group's current deferred revenue for the quarter that ended in Mar. 2026 was $3,419 Mil.
UnitedHealth Group Current Deferred Revenue Related Terms
UnitedHealth Group Current Deferred Revenue Historical Data
* Premium members only.
The historical data trend for UnitedHealth Group's Current Deferred Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Current Deferred Revenue of $3,419 Mil mean?
UnitedHealth Group (UNH) has a Current Deferred Revenue of $3,419 Mil as of Mar. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on UnitedHealth Group and its competitors.
Is UnitedHealth Group's Current Deferred Revenue too high?
UnitedHealth Group's current Current Deferred Revenue is $3,419 Mil. Overall, UnitedHealth Group has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does UnitedHealth Group's Current Deferred Revenue compare to CVS and ELV?
UnitedHealth Group's Current Deferred Revenue of $3,419 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Plans company?
A good Current Deferred Revenue depends on the Healthcare Plans industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on UnitedHealth Group and its competitors. UnitedHealth Group's current Current Deferred Revenue is $3,419 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UnitedHealth Group stock overvalued right now?
Based on GuruFocus' analysis, UnitedHealth Group (UNH) is currently considered Significantly Undervalued. The stock's GF Value™ is $604.48, compared to a current price of $415.36 — trading 31.3% below its estimated fair value. The current Current Deferred Revenue is $3,419 Mil. UnitedHealth Group's overall GF Score™ is 78/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For UnitedHealth Group (UNH), the current Current Deferred Revenue is $3,419 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is UnitedHealth Group (UNH) Overvalued in 2026?
Based on GuruFocus' analysis, UnitedHealth Group stock appears to be undervalued.
The current stock price of $415.36 is trading 31.3% below its estimated GF Value™ of $604.48.
GuruFocus considers UnitedHealth Group to be Significantly Undervalued.
Key valuation signals for UNH:
Current Deferred Revenue: $3,419 Mil
GF Value™: $604.48 vs. price of $415.36 (31.3% below fair value)
No single metric tells the full story. See the UNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.
78GF Score
Get the complete analysis for UNH
Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UNH has been successfully added to your 
